Chain Biotech Ltd

CHAIN Biotechnology Ltd was founded by Dr Edward Green in 2014 to develop new Clostridium-based microbial technology for high value healthcare products. CHAIN produces novel live biotherapeutic products (LBPs) for chronic gut-related diseases, such as Inflammatory Bowel Disease (IBD).

At the heart of CHAIN’s unique therapeutic platform is a suite of underpinning technologies including a Clostridia culture collection, a proprietary set of plasmid vectors, synthetic biology tools for advanced metabolic engineering, and an advanced in-vivo delivery mechanism using Clostridium.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

CHAIN features in Genetic Engineering & Biotechnology News (GEN)

read more

CHAIN sponsor Nottingham student Biotech Ambassador Award

CHAIN has worked closely with the University of Nottingham since our beginning, and it...

read more

Cancer vaccine firm Oxford Vacmedix announces collaboration & Innovate UK...

Oxford, UK – 2nd July 2019 Oxford Vacmedix UK Limited (OVM), the UK-based biopharma...

read more

CHAIN features in new BIA Life Sciences report

CHAIN’s drug delivery platform and lead product, β-hydroxybutyrate, is highlighted in a new report ‘Catalysing Investment...

read more

CHAIN Appoints New Non-Executive Directors

MARLOW & NOTTINGHAM, UK. — April 8, 2019 – UK microbiome therapeutics company CHAIN...

read more

CHAIN Wins Grants to Expand Platform

CHAIN has been awarded two grants to support its therapeutic delivery platform from Innovate...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now